Abstract 5450: JSKN022, a first in class multi-specific ADC targeting PD-L1 and ITGB6/8 with an innovative DNA topoisomerase I inhibitor demonstrates encouraging efficacy in preclinical models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Ting Xu, Ling Wang, Yongli Dong, Chuankun Shan
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629824